Since the beginning, research has been at the core of EnsoData’s mission. In 2015, our founding team set out to apply the latest in machine learning to fundamentally shift the way clinicians interact with physiologic data in healthcare. Today, we have one of the most widely deployed waveform artificial intelligences being used in real-world clinical settings. The work we do provides us with a unique perch from which we observe how sleep centers across the country are evolving and adjusting to changes in sleep medicine. And there’s never been a bigger, more acute change than the COVID-19 pandemic. In the interest of using our unique perch to best serve the sleep community during this time, we’ve drawn inspiration from our research-based roots. Last week, our team embarked on a nationwide market research project to understand the biggest challenges sleep centers are facing as they adjust patient care and operations in light of COVID. Every day we are talking with ten or more clinical and operational executives to learn about the changes they’ve made – what’s working and what’s not working. Additionally – and what we expect to be most interesting – we’re asking these sleep leaders to share their view on what the future looks like beyond the pandemic.
- What role will remote patient visits play? Will telehealth reimbursement go away?
- Will insurance push even harder for HSTs?
- How long will wait times for in-lab studies get?
- Will a shift to virtual HST and PAP therapy setups become the norm?